[ad_1] Catalent (CTLT) stock launched higher Monday on a rumor that Danaher (DHR) could acquire it in a bid to…
Read More »rocketed
[ad_1] Prometheus Biosciences (RXDX) reported promising results for one of its drugs in two inflammatory disease studies on Wednesday, and…
Read More »